No photo of Robert G Bennett

View Scopus Profile

Robert G Bennett, PhD

  • 1904 Citations
  • 24 h-Index
1990 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Robert G Bennett is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Mechanisms of Antifibrotic Actions of Relaxin in the Liver

Bennett, R. G.

National Institutes of Health

4/1/11 → 3/31/20

Project: Research project

    • RELAXIN FAMILY PEPTIDES AND HEPATIC FIBROSIS

    Bennett, R. G.

    National Institutes of Health

    7/5/07 → 6/30/11

    Project: Research project

    • Research Output

    • 1904 Citations
    • 24 h-Index
    • 37 Article
    • 6 Review article
    • 3 Conference contribution
    • 1 Chapter

    Relaxin and extracellular matrix remodeling: Mechanisms and signaling pathways

    Ng, H. H., Shen, M., Samuel, C. S., Schlossmann, J. & Bennett, R. G., May 1 2019, In : Molecular and Cellular Endocrinology. 487, p. 59-65 7 p.

    Research output: Contribution to journal › Review article

    • 3 Scopus citations

    Relaxin and fibrosis: Emerging targets, challenges, and future directions

    Kanai, A. J., Konieczko, E. M., Bennett, R. G., Samuel, C. S. & Royce, S. G., May 1 2019, In : Molecular and Cellular Endocrinology. 487, p. 66-74 9 p.

    Research output: Contribution to journal › Review article

    • 1 Scopus citations

    Anti-fibrotic actions of relaxin

    Samuel, C. S., Royce, S. G., Hewitson, T. D., Denton, K. M., Cooney, T. E. & Bennett, R. G., Jan 1 2017, In : British Journal of Pharmacology. 174, 10, p. 962-976 15 p.

    Research output: Contribution to journal › Article

    • 42 Scopus citations

    Novel anti-fibrotic therapies

    McVicker, B. L. & Bennett, R. G., May 31 2017, In : Frontiers in Pharmacology. 8, MAY, 318.

    Research output: Contribution to journal › Review article

    • 23 Scopus citations

    Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis

    Bennett, R. G., Simpson, R. L. & Hamel, F. G., Jun 14 2017, In : World Journal of Gastroenterology. 23, 22, p. 3999-4006 8 p.

    Research output: Contribution to journal › Article

    • 7 Scopus citations